NasdaqGM:LGNDPharmaceuticals
Is Ligand Pharmaceuticals (LGND) Still Undervalued After Its Strong Recent Share Price Momentum
Recent performance context for Ligand Pharmaceuticals (LGND)
Without a specific news event driving headlines today, Ligand Pharmaceuticals (LGND) still gives investors some fresh data points to consider, from recent share performance to reported revenue and net income figures.
See our latest analysis for Ligand Pharmaceuticals.
At a share price of $237.00, Ligand Pharmaceuticals has shown solid momentum, with a 17.38% 90 day share price return and a 123.61% 1 year total shareholder return...